🚀 June’s AI-picked stocks soar, with Adobe +18.1% in 11 days. Don’t miss July’s upcoming picks.Unlock full list

UBS raises Mitsubishi Chemical stock target

EditorAhmed Abdulazez Abdulkadir
Published 10/06/2024, 18:12
4188
-

On Monday, Mitsubishi Chemical Holdings (4188:JP) (OTC: MTLHY) saw an upgrade in its stock rating from UBS, moving from Sell to Neutral. The firm also increased the price target to JPY860.00, up from the previous JPY815.00. This adjustment reflects a shift in perspective regarding the company's valuation and future prospects.

The change in rating comes after Mitsubishi Chemical Holdings' shares have reflected the recent earnings decline and delays in business portfolio reforms, having underperformed the TOPIX by 21% over the last six months. UBS now believes that the current stock price has these factors sufficiently accounted for.

The new CEO of Mitsubishi Chemical, Manabu Chikumoto, is recognized for his extensive knowledge of the chemicals industry. His leadership is seen as a potential catalyst for accelerated portfolio reforms. UBS notes that there is a significant need for restructuring within the domestic petrochemicals industry which also requires navigating complex interests.

The potential for Mitsubishi Chemical to overhaul its petrochemicals business and improve its portfolio, which includes pharmaceuticals and industrial gases, is expected to drive better capital efficiency. UBS suggests that these steps towards restructuring could lead to a re-evaluation of the company's stock in the market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.